VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $101,400,000 | +485.3% | 4,363,330 | +300.9% | 0.03% | +250.0% |
Q1 2018 | $17,323,000 | -71.0% | 1,088,470 | -62.1% | 0.01% | -78.9% |
Q4 2017 | $59,660,000 | +34.6% | 2,871,121 | -7.1% | 0.04% | +26.7% |
Q3 2017 | $44,308,000 | +77.2% | 3,092,190 | +114.0% | 0.03% | +66.7% |
Q2 2017 | $25,000,000 | +406.3% | 1,445,248 | +222.7% | 0.02% | +350.0% |
Q1 2017 | $4,938,000 | -44.5% | 447,910 | -27.0% | 0.00% | -42.9% |
Q4 2016 | $8,905,000 | -30.5% | 613,513 | +17.6% | 0.01% | -22.2% |
Q3 2016 | $12,806,000 | +227.1% | 521,742 | +168.3% | 0.01% | +200.0% |
Q2 2016 | $3,915,000 | -85.2% | 194,448 | -80.7% | 0.00% | -85.0% |
Q1 2016 | $26,480,000 | -89.5% | 1,006,962 | -59.3% | 0.02% | -88.5% |
Q4 2015 | $251,420,000 | +330.3% | 2,473,425 | +655.1% | 0.17% | +286.7% |
Q3 2015 | $58,425,000 | -19.2% | 327,560 | +0.6% | 0.04% | -2.2% |
Q2 2015 | $72,319,000 | +7.2% | 325,558 | -4.2% | 0.05% | +9.5% |
Q1 2015 | $67,477,000 | -54.5% | 339,758 | -67.2% | 0.04% | -53.8% |
Q4 2014 | $148,301,000 | -20.5% | 1,036,308 | -27.1% | 0.09% | -21.6% |
Q3 2014 | $186,511,000 | +425.9% | 1,421,614 | +405.5% | 0.12% | +383.3% |
Q2 2014 | $35,463,000 | +73.5% | 281,208 | +80.6% | 0.02% | +60.0% |
Q1 2014 | $20,443,000 | -16.6% | 155,688 | -25.9% | 0.02% | -16.7% |
Q4 2013 | $24,514,000 | +84.2% | 210,096 | +62.6% | 0.02% | +80.0% |
Q3 2013 | $13,310,000 | – | 129,172 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |